IN2014KN02409A - - Google Patents
Info
- Publication number
- IN2014KN02409A IN2014KN02409A IN2409KON2014A IN2014KN02409A IN 2014KN02409 A IN2014KN02409 A IN 2014KN02409A IN 2409KON2014 A IN2409KON2014 A IN 2409KON2014A IN 2014KN02409 A IN2014KN02409 A IN 2014KN02409A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1209013.0A GB201209013D0 (en) | 2012-05-22 | 2012-05-22 | Novel compounds |
| GBGB1209986.7A GB201209986D0 (en) | 2012-06-06 | 2012-06-06 | Novel compounds |
| GBGB1222528.0A GB201222528D0 (en) | 2012-12-13 | 2012-12-13 | Novel uses |
| PCT/GB2013/051343 WO2013175211A1 (en) | 2012-05-22 | 2013-05-22 | Hydantoin derivatives as kv3 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014KN02409A true IN2014KN02409A (en) | 2015-05-01 |
Family
ID=48534442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2409KON2014 IN2014KN02409A (en) | 2012-05-22 | 2014-10-29 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9669030B2 (en) |
| EP (1) | EP2852588B8 (en) |
| JP (1) | JP2015517563A (en) |
| CN (1) | CN104334548A (en) |
| BR (1) | BR112014028718A2 (en) |
| IN (1) | IN2014KN02409A (en) |
| WO (1) | WO2013175211A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2509961T3 (en) | 2009-12-11 | 2016-09-30 | Imidazolidinedione derivatives | |
| JP6008953B2 (en) | 2011-06-07 | 2016-10-19 | アウトイフオンイ トヘラペウトイクス リミテッド | Hydantoin derivatives as KV3 inhibitors |
| BR112014028718A2 (en) | 2012-05-22 | 2017-06-27 | Autifony Therapeutics Ltd | hydantoin derivatives as kv3 inhibitors |
| US9422252B2 (en) | 2012-05-22 | 2016-08-23 | Autifony Therapeutics Limited | Triazoles as Kv3 inhibitors |
| GB201521751D0 (en) | 2015-12-10 | 2016-01-27 | Autifony Therapeutics Ltd | Novel uses |
| GB201522179D0 (en) * | 2015-12-16 | 2016-01-27 | Autifony Therapeutics Ltd | Novel compounds |
| GB201613163D0 (en) | 2016-07-29 | 2016-09-14 | Autifony Therapeutics Ltd | Novel compounds |
| US20200039970A1 (en) | 2016-12-16 | 2020-02-06 | Autifony Therapeutics Limited | Hydantoin modulators of kv3 channels |
| CA3110251A1 (en) * | 2018-09-21 | 2019-11-28 | Bionomics Limited | Substituted-pyridinyl compounds and uses thereof |
| US12358901B2 (en) * | 2018-10-16 | 2025-07-15 | Autifony Therapeutics Limited | KV3 modulators |
| HRP20241318T1 (en) | 2018-10-16 | 2024-12-20 | Autifony Therapeutics Limited | Novel compounds |
| EP3947365B1 (en) * | 2019-03-25 | 2025-10-01 | Bionomics Limited | Substituted-n-heteroaryl compounds and uses thereof |
| PH12022551955A1 (en) | 2020-02-06 | 2023-10-23 | Autifony Therapeutics Ltd | Novel compound |
| IL310160A (en) | 2021-08-10 | 2024-03-01 | Autifony Therapeutics Ltd | Potassium channel modulators |
| WO2024121552A1 (en) | 2022-12-06 | 2024-06-13 | Autifony Therapeutics Limited | Compounds for the treatment of centra nervous system disorders |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3015090A1 (en) | 1980-04-19 | 1981-10-22 | Basf Ag, 6700 Ludwigshafen | ] - (TRIHALOGENMETHYL-SULFENYL) -4-ARYL-1,2,4-TRIAZOLIDINE-5-ONE, METHOD FOR THE PRODUCTION THEREOF, FUNGICIDES CONTAINING THEM AND METHOD FOR CONTROLLING FUNGI WITH THESE COMPOUNDS |
| DE3133405A1 (en) | 1981-08-24 | 1983-03-10 | Basf Ag, 6700 Ludwigshafen | 1- (TRIHALOGENMETHYL-SULFENYL) -4-ARYL-1,2,4-TRIAZOLIDIN-5-ONE AND FUNGICIDES CONTAINING THEM |
| US4675403A (en) | 1985-10-16 | 1987-06-23 | American Home Products Corporation | 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity |
| JP2514945B2 (en) | 1987-02-05 | 1996-07-10 | 三井石油化学工業株式会社 | Aromatic amine derivative |
| DE3810848A1 (en) | 1988-03-30 | 1989-10-19 | Boehringer Ingelheim Kg | NEW 2,3,4-SUBSTITUTED IMIDAZOLE AND 3,4,5-SUBSTITUTED 1,2,4-TRIAZOLE, THEIR PREPARATION AND USE |
| DE3836175A1 (en) | 1988-10-24 | 1990-05-03 | Bayer Ag | FLUOR CONTAINING PHENOLES |
| WO1991004027A1 (en) | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| US5362878A (en) | 1991-03-21 | 1994-11-08 | Pfizer Inc. | Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) |
| US6002016A (en) | 1991-12-20 | 1999-12-14 | Rhone-Poulenc Agrochimie | Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones |
| DK123493D0 (en) | 1993-11-01 | 1993-11-01 | Lundbeck & Co As H | COMPOUNDS |
| MX9708802A (en) | 1995-05-17 | 1998-02-28 | Du Pont | Fungicidal cyclic amides. |
| WO1996036229A1 (en) | 1995-05-17 | 1996-11-21 | E.I. Du Pont De Nemours And Company | Fungicidal cyclic amides |
| HUP9901228A3 (en) | 1995-06-20 | 2001-11-28 | Du Pont | Cyclic amides, their intermediates, arthropodicide and fungicide compositions containing theses compounds as active ingredients and use thereof |
| AU3889097A (en) | 1996-08-01 | 1998-02-25 | E.I. Du Pont De Nemours And Company | Arthropodicidal and fungicidal cyclic amides |
| JP2001506984A (en) | 1996-11-26 | 2001-05-29 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | Methyl-substituted fungicides and arthropodicides |
| WO1998023155A1 (en) | 1996-11-26 | 1998-06-04 | E.I. Du Pont De Nemours And Company | Arthropodicidal and fungicidal cyclic amides |
| WO1998033382A1 (en) | 1997-01-30 | 1998-08-06 | E.I. Du Pont De Nemours And Company | Fungicidal compositions |
| JP4171549B2 (en) | 1998-01-28 | 2008-10-22 | 大正製薬株式会社 | Fluorine-containing amino acid derivatives |
| JP4194715B2 (en) | 1998-08-31 | 2008-12-10 | 大正製薬株式会社 | 6-Fluorobicyclo [3.1.0] hexane derivative |
| JP2000072731A (en) | 1998-08-31 | 2000-03-07 | Taisho Pharmaceut Co Ltd | 4-Substituted-2-aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivative and pharmaceutical composition |
| KR20020012309A (en) | 1999-07-23 | 2002-02-15 | 시오노 요시히코 | Th2 differentiation inhibitors |
| WO2001074331A1 (en) | 2000-04-04 | 2001-10-11 | Shionogi & Co., Ltd. | Oily compositions containing highly fat-soluble drugs |
| AU2001244610A1 (en) | 2000-04-05 | 2001-10-23 | Shionogi And Co., Ltd. | Oil-in-water microemulsions containing tricyclic compounds or preconcentrates thereof |
| FR2812633A1 (en) | 2000-08-04 | 2002-02-08 | Aventis Cropscience Sa | PHENYL (THIO) UREA AND PHENYL (THIO) CARBAMATE FUNGICIDES DERIVATIVES |
| US7429599B2 (en) * | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| JPWO2003048134A1 (en) | 2001-12-05 | 2005-04-14 | 日本たばこ産業株式会社 | Triazole compounds and pharmaceutical use thereof |
| DE60322680D1 (en) | 2002-02-07 | 2008-09-18 | Univ Missouri | OPIOID RECEPTOR ACTIVES 4- (3-HYDROXYPHENYL) OR 4- (3-ALKOXYPHENYL) -1,2,4-TRIAZOL COMPOUNDS |
| AU2004236239A1 (en) | 2003-04-30 | 2004-11-18 | The Institutes For Pharmaceutical Discovery, Llc | Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| WO2005000309A2 (en) | 2003-06-27 | 2005-01-06 | Ionix Pharmaceuticals Limited | Chemical compounds |
| GB0325175D0 (en) | 2003-10-28 | 2003-12-03 | Novartis Ag | Organic compounds |
| US7256208B2 (en) | 2003-11-13 | 2007-08-14 | Bristol-Myers Squibb Company | Monocyclic N-Aryl hydantoin modulators of androgen receptor function |
| HUP0401523A3 (en) * | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
| US20060211697A1 (en) | 2004-12-08 | 2006-09-21 | Liren Huang | 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents |
| KR101782236B1 (en) | 2005-05-13 | 2017-09-26 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Diarylhydantoin compounds |
| US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
| PT2368550E (en) | 2006-03-27 | 2013-12-03 | Univ California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
| CN101460467B (en) | 2006-03-29 | 2012-09-19 | 加利福尼亚大学董事会 | Diarylthiohydantoins |
| BRPI0807717A2 (en) | 2007-04-20 | 2014-05-20 | Deciphera Pharmaceuticals Llc | KINASE INHIBITORS USEFUL FOR TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES. |
| WO2009097997A1 (en) | 2008-02-07 | 2009-08-13 | Sanofi-Aventis | Substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| BRPI0924121A2 (en) | 2008-12-22 | 2019-09-24 | Hoffmann La Roche | heterocyclic antiviral compounds |
| PL2509961T3 (en) * | 2009-12-11 | 2016-09-30 | Imidazolidinedione derivatives | |
| CA2780526A1 (en) | 2009-12-14 | 2011-06-23 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
| US9346790B2 (en) * | 2010-12-06 | 2016-05-24 | Autifony Therapeutics Limited | Hydantoin derivatives useful as Kv3 inhibitors |
| FR2968721B1 (en) * | 2010-12-09 | 2015-07-24 | Valeo Equip Electr Moteur | MOTOR VEHICLE STARTER CIRCUIT HAVING A BATTERY VOLTAGE ENHANCEMENT DEVICE AND EQUIPPED STARTER |
| GB201209986D0 (en) | 2012-06-06 | 2012-07-18 | Autifony Therapeutics Ltd | Novel compounds |
| JP6008953B2 (en) * | 2011-06-07 | 2016-10-19 | アウトイフオンイ トヘラペウトイクス リミテッド | Hydantoin derivatives as KV3 inhibitors |
| PL2788339T3 (en) | 2011-12-06 | 2016-09-30 | Hydantoin derivatives useful as kv3 inhibitors | |
| BR112014028718A2 (en) | 2012-05-22 | 2017-06-27 | Autifony Therapeutics Ltd | hydantoin derivatives as kv3 inhibitors |
| US9422252B2 (en) * | 2012-05-22 | 2016-08-23 | Autifony Therapeutics Limited | Triazoles as Kv3 inhibitors |
| WO2013182851A1 (en) | 2012-06-06 | 2013-12-12 | Autifony Therapeutics Limited | Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required |
-
2013
- 2013-05-22 BR BR112014028718A patent/BR112014028718A2/en not_active IP Right Cessation
- 2013-05-22 WO PCT/GB2013/051343 patent/WO2013175211A1/en not_active Ceased
- 2013-05-22 JP JP2015513268A patent/JP2015517563A/en active Pending
- 2013-05-22 US US14/403,011 patent/US9669030B2/en not_active Expired - Fee Related
- 2013-05-22 CN CN201380026712.4A patent/CN104334548A/en active Pending
- 2013-05-22 EP EP13725443.9A patent/EP2852588B8/en active Active
-
2014
- 2014-10-29 IN IN2409KON2014 patent/IN2014KN02409A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2852588A1 (en) | 2015-04-01 |
| EP2852588B1 (en) | 2017-11-29 |
| US9669030B2 (en) | 2017-06-06 |
| WO2013175211A1 (en) | 2013-11-28 |
| US20150157631A1 (en) | 2015-06-11 |
| EP2852588B8 (en) | 2018-01-10 |
| BR112014028718A2 (en) | 2017-06-27 |
| JP2015517563A (en) | 2015-06-22 |
| CN104334548A (en) | 2015-02-04 |